Sarepta Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Daiichi Sankyo JPY 50B 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 0 2025-03
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2024-12
Tectonic Therapeutic USD 2K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Sarepta Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.